PLSE

NASD Pulse Biosciences, Inc.
Oct 21, 2026 · 6:37 PM ET LAST TRADE Market Closed

$52.24 ↑ +0.93 (+1.81%) Trading Up from the previous close of $51.31, and at the day’s high of $52.03

YTD change
+280.48%
vs 20-day SMA
+4.99%
vs 200-day SMA
+75.24%

Price ranges

Previous day
$47.25 $52.33
open $47.25 close $50.84
+$3.59 (+7.60%)
Today
$50.07 $52.03
open $51.16 now $52.24
+$1.08 (+2.11%)
Past week
$43.32 $52.33
from $48.54 now $52.24
+$3.70 (+7.62%)
Past month
$43.32 $56.74
from $52.69 now $52.24
-$0.45 (-0.85%)
This year
$13.17 $58.90
from $13.73 now $52.24
+$38.51 (+280.48%)

Price & Performance

+26.86 (+112.01%) / 6M

$15.73$29.86$43.99$58.12Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 11.3% away from all-time highs of $58.90
  • PLSE is up 280% since the beginning of the year
  • PLSE is up 189% over the past 12 months
  • PLSE is down 1% over the past 1 month
  • 16% of all PLSE investors are betting against PLSE

PLSE reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +181.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.284451
Earnings momentum +8.1% Quarterly EPS growth
Quarterly change +8.1%

Valuation

P/E ratio N/A
Enterprise value $3.4B
Beta 2.67

Balance sheet & scale

IncomeN/A
Revenue$1.2M
Cash$101.6M
Debt$6.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Computer and Electronic Product Manufacturing
Market cap $3.7B

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Competitor comparison

TickerCompany PriceChange
TMO Thermo Fisher Scientific Inc. $687.37 +1.18%
ABT Abbott Laboratories $102.45 -1.55%
ISRG Intuitive Surgical, Inc. $438.00 +1.11%
MDT Medtronic Plc $94.63 +2.00%
BSX Boston Scientific Corporation $45.58 +1.18%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.